Format

Send to

Choose Destination
Rheumatol Int. 2018 Apr;38(Suppl 1):43-49. doi: 10.1007/s00296-018-3979-3. Epub 2018 Apr 7.

The Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Author information

1
Department of Pediatric Rheumatology, King Faisal Specialist Hospital and Research Center, Alfaisal University, PO Box 3354, Riyadh, 11211, Saudi Arabia. mayouf@kfshrc.edu.sa.
2
Department of Pediatric Rheumatology, King Faisal Specialist Hospital and Research Center, Alfaisal University, PO Box 3354, Riyadh, 11211, Saudi Arabia.
3
Department of Pediatrics, King Abdualziz University Hospital, Jeddah, Saudi Arabia.
4
Clinica Pediatrica e Reumatologia, Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto Giannina Gaslini, Via Gaslini 5, 16147, Genoa, Italy.
5
Dipartimento di Pediatria, Università di Genova, Genoa, Italy.
6
Clinica Pediatrica e Reumatologia, Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto Giannina Gaslini, Via Gaslini 5, 16147, Genoa, Italy. nicolaruperto@gaslini.org.

Abstract

The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Arabic language. The reading comprehension of the questionnaire was tested in 10 JIA parents and patients. Each participating centre was asked to collect demographic and clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the 3 Likert assumptions, floor/ceiling effects, internal consistency, Cronbach's alpha, interscale correlations, test-retest reliability, and construct validity (convergent and discriminant validity). A total of 100 JIA patients (27.0% systemic JIA, 23.0% oligoarticular, 25.0% RF negative polyarthritis, and 25.0% other categories) and 100 healthy children, were enrolled in one paediatric rheumatology centre. The JAMAR components discriminated well healthy subjects from JIA patients. All JAMAR components revealed satisfactory psychometric performances. In conclusion, the Arabic version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and in clinical research.

KEYWORDS:

Disease status; Functional ability; Health-related quality of life; JAMAR; Juvenile idiopathic arthritis

PMID:
29637351
PMCID:
PMC5893675
DOI:
10.1007/s00296-018-3979-3
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center